Cargando…

Synchrony 2022: Roundtable Discussion on the Pathways and the Challenges of Getting Medications FDA Approved

Detalles Bibliográficos
Autores principales:	Belfort, Gabriel, Nanda, Heer, Slattery, John C., Sambor, Joanna, Rodakis, John, Frye, Richard E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222728/ https://www.ncbi.nlm.nih.gov/pubmed/37240949 http://dx.doi.org/10.3390/jpm13050779

Ejemplares similares

Synchrony 2022: Epilepsy and Seizures in Autism Spectrum Disorder Roundtable
por: Frye, Richard E., et al.
Publicado: (2023)

Synchrony 2022: Catalyzing Research and Treatments to Benefit Individuals with Neurodevelopmental Disorders including Autism Spectrum Disorders
por: Nanda, Heer, et al.
Publicado: (2023)

FDA Approvals of Biologics in 2022
por: Martins, Alexander C., et al.
Publicado: (2023)

Synchrony 2022: The Role of Neuroinflammation in Behavioral Exacerbations in Autism Spectrum Disorder
por: Frankovich, Jennifer, et al.
Publicado: (2023)

FDA-Approved Small Molecules in 2022: Clinical Uses and Their Synthesis
por: Benedetto Tiz, Davide, et al.
Publicado: (2022)

FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022
por: Rizzo, Carla, et al.
Publicado: (2023)

Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016–2022)
por: Shabir, Ghulam, et al.
Publicado: (2023)

Synthesis and clinical application of new drugs approved by FDA in 2022
por: Zhang, Jing-Yi, et al.
Publicado: (2023)

Biosimilars: Extrapolating the evidence. A roundtable discussion
por: Monk, Bradley J., et al.
Publicado: (2015)

Animal Models of Craving: A Roundtable Discussion
por: Vann, Barbara Breen
Publicado: (1999)

Roundtable Discussion: Making Sense of Current Liposuction Technologies
por: Cook, Jonathan, et al.
Publicado: (2021)

The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules
por: de la Torre, Beatriz G., et al.
Publicado: (2023)

Roundtable discussion: what is the future role of the private sector in health?
por: Stallworthy, Guy, et al.
Publicado: (2014)

Fat Transfer for Gluteal Augmentation: An Expert Video Roundtable Discussion
por: Kenkel, Jeffrey M, et al.
Publicado: (2022)

Guidelines for genetic ancestry inference created through roundtable discussions
por: Wagner, Jennifer K., et al.
Publicado: (2023)

Health Information Technology—Results From a Roundtable Discussion
por: Balfour, Donald C., et al.
Publicado: (2009)

FDA approved antibacterial drugs: 2018-2019
por: Andrei, Stefan, et al.
Publicado: (2019)

Implementation of lung cancer screening in Europe: challenges and potential solutions: summary of a multidisciplinary roundtable discussion
por: Field, John K, et al.
Publicado: (2019)

A Roundtable Discussion: Challenges for a Sustainable Aluminum Industry and Advice for the Next Generation
Publicado: (2020)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

Roundtable discussion on EPA held on 8th March 1982 at CERN
por: Kugler, H
Publicado: (1982)

Transnational Child Sexual Abuse: Outcomes from a Roundtable Discussion
por: Merdian, Hannah L., et al.
Publicado: (2019)

Medicare Part D—A Roundtable Discussion of Current Issues and Trends
por: Balfour, Donald, et al.
Publicado: (2009)

New FDA approved antibacterial drugs: 2015-2017
por: Andrei, Stefan, et al.
Publicado: (2018)

Why Did the FDA Approve These Advertisements?
por: Oaks, David
Publicado: (2006)

FDA approved ready to use phenylephrine
por: Bhatia, Pradeep Kumar, et al.
Publicado: (2021)

An insider's perspective on FDA approval of aducanumab
por: Wang, Yaning
Publicado: (2023)

Alchemical analysis of FDA approved drugs
por: Orsi, Markus, et al.
Publicado: (2023)

FDA efficiency for approval process of COVID-19 therapeutics
por: Cassidy, Christine, et al.
Publicado: (2020)

RESILIENT AGING ROUNDTABLE: AN EVALUATION OF A BRIEF COMMUNITY PSYCHOEDUCATION DISCUSSION GROUP
por: June, Andrea, et al.
Publicado: (2019)

Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
por: Boyiadzis, Michael M., et al.
Publicado: (2018)

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

FDA-approved medications that impair human spermatogenesis
por: Ding, Jiayi, et al.
Publicado: (2016)

The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021)

FDA-Approved Oximes and Their Significance in Medicinal Chemistry
por: Dhuguru, Jyothi, et al.
Publicado: (2022)

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
por: Cho, Su Min, et al.
Publicado: (2022)

FDA approved vaccines for monkeypox: Current eminence
por: Chopra, Hitesh, et al.
Publicado: (2022)

Proposal for a high-level roundtable discussion in the context of the inauguration of the CERN Science Gateway
Publicado: (2023)

What to do about portion sizes? Roundtable discussion at the forefronts in portion size conference
por: Raynor, H A
Publicado: (2014)

Learning by doing in practice: a roundtable discussion about stakeholder engagement in implementation research
por: Arwal, Said Habib, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_medgqfrpn7sq0blutgo4r37vr2